Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Cue Biopharma (CUE) Insider Trading & Ownership

→ Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad)
Free CUE Stock Alerts
$1.71
-0.03 (-1.72%)
(As of 05/17/2024 08:53 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Cue Biopharma (NASDAQ:CUE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.24%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$19,620.00
Number Of
Insiders Selling
(Last 12 Months)
0

CUE Insider Buying and Selling by Quarter

Ad InvestorPlace
Crypto Pioneer Says: “The last crypto bull market has begun.”
Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.
Click here if you’d like to learn more about these five cryptos…

Cue Biopharma Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/25/2023Anish SuriInsiderBuy4,000$2.76$11,040.00  
8/14/2023Daniel R PasseriCEOBuy3,000$2.86$8,580.00  
(Data available from 1/1/2013 forward)

CUE Insider Trading Activity - Frequently Asked Questions

Who is on Cue Biopharma's Insider Roster?

The list of insiders at Cue Biopharma includes Aaron G.L. Fletcher, Anish Suri, Daniel R Passeri, Kerri-Ann Millar, and Peter A Kiener. Learn more on insiders at CUE.

What percentage of Cue Biopharma stock is owned by insiders?

10.24% of Cue Biopharma stock is owned by insiders. Learn more on CUE's insider holdings.

Which Cue Biopharma insiders have been buying company stock?

The following insiders have purchased CUE shares in the last 24 months: Aaron G.L. Fletcher ($528,000.00), Anish Suri ($11,040.00), and Daniel R Passeri ($8,580.00).

How much insider buying is happening at Cue Biopharma?

Insiders have purchased a total of 157,000 CUE shares in the last 24 months for a total of $547,620.00 bought.

Which Cue Biopharma insiders have been selling company stock?

The following insider sold CUE shares in the last 24 months: Peter A Kiener ($30,586.00).

How much insider selling is happening at Cue Biopharma?

Insiders have sold a total of 9,325 Cue Biopharma shares in the last 24 months for a total of $30,586.00 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:CUE) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Elon’s New Device is About to Shock the World
InvestorPlace
Dems have chosen Biden replacement?
Paradigm Press
Bill Gates is all about this tiny $2 stock
Timothy Sykes
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits